000 01572 a2200481 4500
005 20250514011621.0
264 0 _c20011101
008 200111s 0 0 eng d
022 _a0002-953X
024 7 _a10.1176/appi.ajp.158.10.1719
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEder, U
245 0 0 _aAssociation of olanzapine-induced weight gain with an increase in body fat.
_h[electronic resource]
260 _bThe American journal of psychiatry
_cOct 2001
300 _a1719-22 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdipose Tissue
_xdrug effects
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aBenzodiazepines
650 0 4 _aBody Composition
_xdrug effects
650 0 4 _aBody Mass Index
650 0 4 _aFeeding Behavior
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeptin
_xblood
650 0 4 _aMale
650 0 4 _aOlanzapine
650 0 4 _aPirenzepine
_xadverse effects
650 0 4 _aProspective Studies
650 0 4 _aSchizophrenia
_xblood
650 0 4 _aWeight Gain
_xdrug effects
700 1 _aMangweth, B
700 1 _aEbenbichler, C
700 1 _aWeiss, E
700 1 _aHofer, A
700 1 _aHummer, M
700 1 _aKemmler, G
700 1 _aLechleitner, M
700 1 _aFleischhacker, W W
773 0 _tThe American journal of psychiatry
_gvol. 158
_gno. 10
_gp. 1719-22
856 4 0 _uhttps://doi.org/10.1176/appi.ajp.158.10.1719
_zAvailable from publisher's website
999 _c11500545
_d11500545